Bergsagel PL - Search Results

1

NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma.

Mattarollo SR, West AC, Steegh K, Duret H, Paget C, Martin B, Matthews GM, Shortt J, Chesi M, Bergsagel PL, Bots M, Zuber J, Lowe SW, Johnstone RW, Smyth MJ. Mattarollo SR, et al. Among authors: bergsagel pl. Blood. 2012 Oct 11;120(15):3019-29. doi: 10.1182/blood-2012-04-426643. Epub 2012 Aug 28. Blood. 2012. PMID: 22932803 Free PMC article.

2

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Chesi M, et al. Among authors: bergsagel pl. Blood. 1996 Jul 15;88(2):674-81. Blood. 1996. PMID: 8695815 Free article.

3

Selective expression of one c-myc allele in two human myeloma cell lines.

Kuehl WM, Brents LA, Chesi M, Bergsagel PL. Kuehl WM, et al. Among authors: bergsagel pl. Cancer Res. 1996 Oct 1;56(19):4370-3. Cancer Res. 1996. PMID: 8813127

4

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM. Chesi M, et al. Among authors: bergsagel pl. Blood. 1998 Jun 15;91(12):4457-63. Blood. 1998. PMID: 9616139 Free article.

5

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.

Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Blood. 1998 Nov 1;92(9):3025-34. Blood. 1998. PMID: 9787135 Free article.

6

Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.

Plowright EE, Li Z, Bergsagel PL, Chesi M, Barber DL, Branch DR, Hawley RG, Stewart AK. Plowright EE, et al. Among authors: bergsagel pl. Blood. 2000 Feb 1;95(3):992-8. Blood. 2000. PMID: 10648414 Free article.

7

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

Chesi M, Brents LA, Ely SA, Bais C, Robbiani DF, Mesri EA, Kuehl WM, Bergsagel PL. Chesi M, et al. Among authors: bergsagel pl. Blood. 2001 Feb 1;97(3):729-36. doi: 10.1182/blood.v97.3.729. Blood. 2001. PMID: 11157491 Free article.

8

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.

Li Z, Zhu YX, Plowright EE, Bergsagel PL, Chesi M, Patterson B, Hawley TS, Hawley RG, Stewart AK. Li Z, et al. Among authors: bergsagel pl. Blood. 2001 Apr 15;97(8):2413-9. doi: 10.1182/blood.v97.8.2413. Blood. 2001. PMID: 11290605 Free article.

9

The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.

Chesi M, Bergsagel PL, Kuehl WM. Chesi M, et al. Among authors: bergsagel pl. Curr Opin Hematol. 2002 Jul;9(4):288-93. doi: 10.1097/00062752-200207000-00005. Curr Opin Hematol. 2002. PMID: 12042702 Review.

10

Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma.

Cao S, Liu J, Chesi M, Bergsagel PL, Ho IC, Donnelly RP, Ma X. Cao S, et al. Among authors: bergsagel pl. J Immunol. 2002 Nov 15;169(10):5715-25. doi: 10.4049/jimmunol.169.10.5715. J Immunol. 2002. PMID: 12421951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters